EPIC III
The Extended Study on Prevalence of Infection in Intensive Care
EPIC III: The Extended Study on Prevalence of Infection in Intensive Care
Up-to-date epidemiological data are essential in critical care medicine. The EPIC study was performed in 19921 and EPIC II in 2007.2 Now, 10 years later it is time for EPIC III!
EPIC III (a 24-hour point-prevalence study) will be performed on September 13, 2017, World Sepsis Day. Data will be collected on: demographics, infection management, degree of organ dysfunction and patient outcomes.
To make this project really worthwhile, we need to enrol as many units as possible in as many countries as possible worldwide – so please join us in this exciting project! Data collection will be limited to simple variables that are easy to collect and routinely recorded. Data will be recorded using electronic case report forms (eCRF) (paper versions can be provided if online access is problematic or not available).
This study will be observational and non-interventional, and patient data will be anonymous. Nevertheless, you will probably want to inform your ethical committee according to local requirements.
EPIC III is supported by the World Federation of Societies of Intensive and Critical Care Medicine.
If you are interested in joining us in this exciting venture, please click here to register. You will also be able to download the study protocol and sample eCRF.
Please also forward this invitation to colleagues on other units.
Jean-Louis Vincent
on behalf of the Steering committee:
Ignacio Martin-Loeches, Simon Finfer, John Marshall, Flavia Machado, Mervyn Singer, Jean-Francois Timsit, Yasser Sakr, Marc Bonten, Marin Kollef, Derek Angus, Bin Du
References
1. Vincent JL, Bihari D, Suter PM, et al: The prevalence of nosocomial infection in intensive care units in Europe - The results of the EPIC study. JAMA 274:639-644, 1995.
2. Vincent JL, Rello J, Marshall JC, et al: International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323-2329, 2009
